According to the market analysis report titled ‘U.S. Dialysis Market Size By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service (Equipment {Dialysis Machines, Water Treatment Systems}, Consumables {Dialyzers, Catheters, Access Products, Concentrates}, Services {Acute Dialysis, Chronic Dialysis), By End-use (In-center Dialysis, Home Dialysis), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with MarketStudyReport, the US dialysis market is slated to accumulate strong returns during 2021-2027.
 

Conclusive findings by experts state that the increasing prevalence diabetes and other diseases is a primary factor fueling the growth of the U.S. dialysis market. Besides, rising investments in R&D, increase in the number of renal patients, shortage of donor kidneys, and growing accessibility of reimbursement for dialysis treatment are adding to the overall value.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4202310/
 

The ongoing Covid-19 pandemic also plays a key role in aiding the surge in product demand as conclusive evidence states that patients who tested positive for coronavirus also developed acute kidney injury (AKI) and other kidney ailments.  
 

Despite the positive industry outlook, complications that arise during the treatment procedures may hinder growth in the upcoming years.
 

Based on type, peritoneal dialysis sub-segment captured 10.5% of U.S. dialysis industry share in 2020 and is slated to grow at a robust pace during the analysis period. This can be ascribed to the growing preference for peritoneal dialysis as it is a technologically advanced procedure as compared to other alternatives.
 

On the basis of product & service, the equipment sub-segment amassed a valuation of USD 2 Bn in 2020 as is projected to record a healthy growth rate during the assessment timeline.
 

With respect to the application spectrum, the in-center dialysis sub-segment is expected to progress at a CAGR of 6% during 2021-2027.
 

From a regional frame of reference, the U.S. dialysis market spans across the East South Central, West South Central, Pacific Central, East North Central, West North Central, and Mountain States. Among these, the West South-Central landscape held 13.5% industry share in 2020 and is expected to accumulate a substantial revenue over the forecast period owing to an increase in the incidences of different ailments in the area.
 

Speaking of the competitive landscape, Renal Care, Inc., Toray Industries, Inc., Nipro Corporation, Medtronic plc, Sanderling Renal Services, LLC, DaVita Inc., Baxter International Inc., Fresenius Medical Care AG & Co., B. Braun Melsungen AG, American Renal Associates Holdings, Inc., and Asahi Kasei Corporation are the key players in the marketplace.